From the known clinicopathologic prognostic factors an AFP level above 400 μgL−1 (p = 0.002), multiple lesions (p = 0.043) and tumor size >3 cm (p = 0.024) were associated with poor HCC-specific survival in the combined cohort (Fig. S1). This evidence concerns the gene AFP and hepatocellular carcinoma.